Delaying prostate cancer radiation therapy offers room for flexibility in pandemic peak

(Brigham and Women's Hospital) A new study by investigators from Brigham and Women's Hospital found that for men with unfavorable intermediate-risk or high-risk localized prostate cancer, who are receiving radiation and hormone therapy, delaying radiation while remaining on hormone therapy is unlikely to impact survival.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news